S. Goulden

Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictions.

Belen Corbacho, Sarah Kleijnen, Steffen Thirstrup, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Organolepsis and nutrition : the sensory perception of food 347 the

J., A. Melton, S. Goulden, 2005 .

NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib.

F. Sutcliffe, A. Stevens, S. Goulden, 2012, The Lancet. Oncology.

Outcomes for Dostarlimab and Real-World Treatments in Post-platinum Patients With Advanced/Recurrent Endometrial Cancer: The GARNET Trial Versus a US Electronic Health Record-Based External Control Arm

Ankit Pahwa, S. Goulden, René Schade, 2023, Journal of health economics and outcomes research.

Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer: data from the GARNET trial and the National Cancer Registration Service in England

M. Hunger, Craig Knott, Ankit Pahwa, 2023, International Journal of Gynecological Cancer.